UCHL1 and plasmacytoma: Our previous work revealed that transgenic mice over-expressing UCH-L1 developed B-cell lymphomas and plasmacytomas, demonstrating that UCH-L1 is not simply another gene that associates with prognosis – but rather is a mechanistic biomarker involved in disease pathogenesis.